Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Pulmonary Circulation|April 15, 2020
Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype?Andrew J Peacock, Yi Ling, Martin K Johnson, et al.
American Journal of Respiratory and Critical Care Medicine|July 17, 2012
Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and IrelandYi Ling, Martin K Johnson, David G Kiely, et al.
Circulation|August 1, 2013
Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatmentsLan Zhao, Ali Ashek, Lei Wang, et al.
American Journal of Respiratory and Critical Care Medicine|December 11, 2012
Reduced microRNA-150 is associated with poor survival in pulmonary arterial hypertensionChristopher J Rhodes, John Wharton, Reinier A Boon, et al.
The European Respiratory Journal|September 11, 2023
Effects of sotatercept on haemodynamics and right heart function: analysis of the STELLAR trialRogerio Souza, David B Badesch, H Ardeschir Ghofrani, et al.
Science Translational Medicine|October 27, 2017
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patientsEvangelos D Michelakis, Vikram Gurtu, Linda Webster, et al.
The New England Journal of Medicine|March 6, 2023
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial HypertensionMarius M Hoeper, David B Badesch, H Ardeschir Ghofrani, et al.
Human Mutation|September 8, 2011
Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertensionMd Talat Nasim, Takeshi Ogo, Mohammad Ahmed, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 7, 2024
Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLARMardi Gomberg-Maitland, David B Badesch, J Simon R Gibbs, et al.
The European Respiratory Journal|January 30, 2025
Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studiesMarius M Hoeper, Mardi Gomberg-Maitland, David B Badesch, et al.
Pageof 12